Heart Disease Trial, Recruiting NCT04662970 Sponsor: Medical University Innsbruck Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT04662970
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have recently had a specific type of heart device (called a CRT-D or CRT-P) successfully implanted, where the device includes a special programming feature called SyncAV®
  • People whose heart device is compatible with a cardiac MRI scan (a detailed imaging scan of the heart)
  • People who had a specific type of abnormal heart electrical signal called left bundle branch block before their heart device was implanted
  • People whose heart's electrical delay (called the PQ interval) was 250 milliseconds or less before the device was implanted (confirm with trial site)

Who may not be able to join:

  • People who have a severe blockage in the heart's electrical system (called high-grade AV block)
  • People who have any reason they cannot safely have a cardiac MRI scan, including those who experience severe anxiety in enclosed spaces (claustrophobia)
  • People with very advanced heart failure (classified as NYHA Class IV) or whose heart condition is currently unstable or worsening
  • People whose life expectancy is less than one year
  • Women who are pregnant or who could potentially become pregnant
  • People with a history of drug misuse or substance abuse

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wolfgang Dichtl, MD PhD, Medical University Innsbruck

Phone: 004351250481388

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical University Innsbruck
Registry
ClinicalTrials.gov
Start date
1 January 2020
Est. completion
31 December 2027

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Optimal (shortest) activation time of the right and left ventricular in heart failure patients after CRT implantation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov